Abstract
Trilaciclib Use and Chemotherapy-Induced Myelosuppression Among Patients with ES- SCLC in US Community Oncology Settings
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have